| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962445 | Vaccine | 2016 | 6 Pages |
Abstract
We estimate that the RVI programme causes around 21 intussusception admissions annually in England but, since it prevents around 25,000 gastro-intestinal infection admissions, its benefit/risk profile remains strongly positive.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Julia Stowe, Nick Andrews, Shamez Ladhani, Elizabeth Miller,